Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia

Stopped early · Phase 2/Phase 3

Conditions studied: Lung Cancer, Prostate Cancer, Neoplasm Metastasis, Bone Cancer

In brief

Patients who receive radiation therapy often have fatigue or a decrease in feeling well causing a "wasting" away. For patients with advanced disease of lung cancer, prostate cancer, or cancer that has spread to the bone, it is hoped that this drug may decrease this. If patients feel better during treatments they can complete the therapy without any breaks in treatment. For treatment to be most effective, it should be given in the amount needed, on a particular schedule.

Key facts

Study ID

NCT00127387

Run by

The University of Texas Health Science Center at San Antonio

People needed

54

Starts

2001-05-01

Expected to finish

2005-11-01

Last updated by the study team

2012-06-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Advanced lung, prostate, or bony metastasis for cancer
• Performance status (PS) of 3 or less
• Good lab test results with albumin of at least 2.5
• Radiation therapy of at least 4000Gy in 4 weeks

You may not qualify if…

• Poor PS
• Planned radiation therapy for less than 4 weeks or 4000Gy
• Limited disease

Where it is running

• University of Texas Health Science Center at San Antonio — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.